These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8166305)

  • 1. Cerebral glucose metabolism in adults with attention deficit hyperactivity disorder after chronic stimulant treatment.
    Matochik JA; Liebenauer LL; King AC; Szymanski HV; Cohen RM; Zametkin AJ
    Am J Psychiatry; 1994 May; 151(5):658-64. PubMed ID: 8166305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of acute stimulant medication on cerebral metabolism in adults with hyperactivity.
    Matochik JA; Nordahl TE; Gross M; Semple WE; King AC; Cohen RM; Zametkin AJ
    Neuropsychopharmacology; 1993 Jun; 8(4):377-86. PubMed ID: 8512624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of intravenous dextroamphetamine on brain metabolism in adults with attention-deficit hyperactivity disorder (ADHD). Preliminary findings.
    Ernst M; Zametkin AJ; Matochik JA; Liebenauer L; Fitzgerald GA; Cohen RM
    Psychopharmacol Bull; 1994; 30(2):219-25. PubMed ID: 7831459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A positron emission tomography study of methylphenidate in adults with ADHD: alterations in resting blood flow and predicting treatment response.
    Schweitzer JB; Lee DO; Hanford RB; Tagamets MA; Hoffman JM; Grafton ST; Kilts CD
    Neuropsychopharmacology; 2003 May; 28(5):967-73. PubMed ID: 12700698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
    Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
    Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral glucose metabolism during pharmacologic studies: test-retest under placebo conditions.
    Schmidt ME; Ernst M; Matochik JA; Maisog JM; Pan BS; Zametkin AJ; Potter WZ
    J Nucl Med; 1996 Jul; 37(7):1142-9. PubMed ID: 8965185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorder.
    Schulz KP; Fan J; Bédard AC; Clerkin SM; Ivanov I; Tang CY; Halperin JM; Newcorn JH
    Arch Gen Psychiatry; 2012 Sep; 69(9):952-61. PubMed ID: 22945622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain metabolism in teenagers with attention-deficit hyperactivity disorder.
    Zametkin AJ; Liebenauer LL; Fitzgerald GA; King AC; Minkunas DV; Herscovitch P; Yamada EM; Cohen RM
    Arch Gen Psychiatry; 1993 May; 50(5):333-40. PubMed ID: 8489322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of one-year pharmacological treatment of adult attention-deficit/hyperactivity disorder (ADHD): an open-label prospective study of time in treatment, dose, side-effects and comorbidity.
    Fredriksen M; Dahl AA; Martinsen EW; Klungsøyr O; Haavik J; Peleikis DE
    Eur Neuropsychopharmacol; 2014 Dec; 24(12):1873-84. PubMed ID: 25453480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based study.
    Barbaresi WJ; Katusic SK; Colligan RC; Weaver AL; Leibson CL; Jacobsen SJ
    J Dev Behav Pediatr; 2014 Sep; 35(7):448-57. PubMed ID: 25180895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurocognitive performance and behavioral symptoms in patients with attention-deficit/hyperactivity disorder during twenty-four months of treatment with methylphenidate.
    Wang LJ; Chen CK; Huang YS
    J Child Adolesc Psychopharmacol; 2015 Apr; 25(3):246-53. PubMed ID: 25574708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of methylphenidate on regional brain glucose metabolism in humans: relationship to dopamine D2 receptors.
    Volkow ND; Wang GJ; Fowler JS; Logan J; Angrist B; Hitzemann R; Lieberman J; Pappas N
    Am J Psychiatry; 1997 Jan; 154(1):50-5. PubMed ID: 8988958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid homovanillic acid predicts behavioral response to stimulants in 45 boys with attention deficit/hyperactivity disorder.
    Castellanos FX; Elia J; Kruesi MJ; Marsh WL; Gulotta CS; Potter WZ; Ritchie GF; Hamburger SD; Rapoport JL
    Neuropsychopharmacology; 1996 Feb; 14(2):125-37. PubMed ID: 8822535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Open-Label, Randomized Trial of Methylphenidate and Atomoxetine Treatment in Children with Attention-Deficit/Hyperactivity Disorder.
    Shang CY; Pan YL; Lin HY; Huang LW; Gau SS
    J Child Adolesc Psychopharmacol; 2015 Sep; 25(7):566-73. PubMed ID: 26222447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine responses to methylphenidate and d-amphetamine: applications to attention-deficit disorder.
    Lurie S; O'Quinn A
    J Neuropsychiatry Clin Neurosci; 1991; 3(1):41-50. PubMed ID: 7580171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced brain metabolism in hyperactive girls.
    Ernst M; Liebenauer LL; King AC; Fitzgerald GA; Cohen RM; Zametkin AJ
    J Am Acad Child Adolesc Psychiatry; 1994; 33(6):858-68. PubMed ID: 8083143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.
    Adler LA; Zimmerman B; Starr HL; Silber S; Palumbo J; Orman C; Spencer T
    J Clin Psychopharmacol; 2009 Jun; 29(3):239-47. PubMed ID: 19440077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADHD in girls: clinical comparability of a research sample.
    Sharp WS; Walter JM; Marsh WL; Ritchie GF; Hamburger SD; Castellanos FX
    J Am Acad Child Adolesc Psychiatry; 1999 Jan; 38(1):40-7. PubMed ID: 9893415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind, placebo-controlled trial of dexmethylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in children with attention-deficit/hyperactivity disorder.
    Wigal S; Swanson JM; Feifel D; Sangal RB; Elia J; Casat CD; Zeldis JB; Conners CK
    J Am Acad Child Adolesc Psychiatry; 2004 Nov; 43(11):1406-14. PubMed ID: 15502600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
    Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
    Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.